Enhancement of spontaneous and heat-evoked activity in spinal nociceptive neurons by the endovanilloid/endocannabinoid N-arachidonoyldopamine (NADA)

Journal of Neurophysiology

Volumn 95, Issue 2, 2006, Pages 1207-1212

  Huang, Susan M ^a   Walker, J Michael ^a,b  

^a BROWN UNIVERSITY   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' IODORESINIFERATOXIN; CANNABINOID RECEPTOR ANTAGONIST; DOPAMINE; DRUG RECEPTOR; N ARACHIDONOYLDOPAMINE; RIMONABANT; UNCLASSIFIED DRUG; VANILLOID RECEPTOR; ARACHIDONIC ACID DERIVATIVE; ARACHIDONYL DOPAMINE; DRUG DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN NERVE CELL; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; ELECTROPHYSIOLOGY; MALE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD DORSAL HORN; THERMAL STIMULATION; ACTION POTENTIAL; ANIMAL; BIOLOGICAL RHYTHM; HEAT; HYPERALGESIA; NOCICEPTIVE RECEPTOR; PAIN THRESHOLD; PATHOPHYSIOLOGY; POSTERIOR HORN CELL; SENSORY NERVE CELL; SPRAGUE DAWLEY RAT;

ACTION POTENTIALS; ANIMALS; ARACHIDONIC ACIDS; BIOLOGICAL CLOCKS; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEAT; HYPERALGESIA; MALE; NEURONS, AFFERENT; NOCICEPTORS; PAIN THRESHOLD; POSTERIOR HORN CELLS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33644861384     PISSN: 00223077     EISSN: None     Source Type: Journal    
DOI: 10.1152/jn.00395.2005     Document Type: Article

References (42)

1. Aley KO, Messing RO, Mochly-Rosen D, and Levine JD. Chronic hypersensitivity for inflammatory nociceptor sensitization mediated by the epsilon isozyme of protein kinase C. J Neurosci 20: 4680-4685, 2000.
2. Bisogno T, Melck D, Bobtov MY, Gretskaya NM, Bezuglov V, De Petrocellis L, and Di Marzo V. N-acyl-dopamines: novel synthetic CB1 cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and. in vivo. Biochem J 351: 817-824, 2000.
3. Carstens E. Responses of rat spinal dorsal horn neurons to intracutaneous microinjection of histamine, capsaicin, and other irritants. J Neurophysiol 77: 2499-2514, 1997.
4. Caterina MJ, Leffler A, Malmberg AB, Martin WJ, Trafton J, Petersen-Zeitz KR, Koltzenburg M, Basbaum AI, and Julius D. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 288: 306-313, 2000.
5. Cesare P, Dekker LV, Sardini A, Parker PJ, and McNaughton PA. Specific involvement of PKC-epsilon in sensitization of the neuronal response to painful heat. Neuron 23: 617-624, 1999.
6. Cesare P and McNaughton P. A novel heat-activated current in nociceptive neurons and its sensitization by bradykinin. Proc Natl Acad Sci USA 93: 15435-15439, 1996.
7. Chu CJ, Huang SM, De Petrocellis L, Bisogno T, Ewing SA, Miller JD, Zipkin RE, Daddario N, Appendino G, Di Marzo V, and Walker JM. N-oleoyldopamine: a novel endogenous capsaicin-like lipid that produces hyperalgesia. J Biol Chem 278: 13633-13639, 2003.
8. Davis JB, Gray J, Gunthorpe MJ, Hatcher JP, Davey PT, Overend P, Harries MH, Latcham J, Clapham C, Atkinson K, Hughes SA, Rance K, Grau E, Harper AJ, Pugh PL, Rogers DC, Bingham S, Randall A, and Sheardown SA. Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature 405: 183-187, 2000.
9. Denda M, Fuziwara S, Inou K, Denda S, Akamatsu H, Tomitaka A, and Matsunaga K. Immunoreactivity of VR1 on epidermal keratinocyte of human skin. Biochem Biophys Res Commun 285: 1250-1252, 2001.
10. De Petrocellis L, Bisogno T, Davis JB, Pertwee RG, and Di Marzo V. Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity. FEBS Lett 483: 52-56, 2000.
11. Dickenson AH and Sullivan AF. Subcutaneous formalin-induced activity of dorsal horn neurones in the rat: differential response to an intrathecal opiate administered pre or post formalin. Pain 30: 349-360, 1987.
12. 3 purinoceptor and IB4 binding sites. Eur J Neurosci 11: 946-958, 1999.
13. Harrison S, De Petrocellis L, Trevisani M, Benvenuti F, Bifulco M, Geppetti P, and Di Marzo V. Capsaicin-like effects of N-arachidonoyldopamine in the isolated guinea pig bronchi and urinary bladder. Eur J Pharmacol 475: 107-114, 2003.
14. Hohmann AG and Herkenham M. Cannabinoid receptors undergo axonal flow in sensory nerves. Neurosci 92: 1171-1175, 1999.
15. Huang SM, Bisogno T, Marcello T, Al-Hayani A, De Petrocellis L, Fezza F, Tognetto M, Petros TJ, Krey JF, Chu CJ, Miller JD, Davies SN, Geppetti P, Walker JM, and Di Marzo V. An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc Natl Acad Sci USA 99: 8400-8405, 2002.
16. Hyunh H and Feldt LS. Estimation of the Box correction for degrees of freedom from sample data in randomized block and split-plot designs. J Ed Stat 1: 69-82, 1976.
17. Kelly S and Chapman V. Spinal administration of capsazepine inhibits noxious evoked responses of dorsal horn neurons in non-inflamed and carrageenan inflamed rats. Brain Res 935: 103-108, 2002.
18. Kelly S, Jhaveri MD, Sagar DR, Kendall DA, and Chapman V. Activation of peripheral cannabinoid CB1 receptors inhibits mechanically evoked responses of spinal neurons in noninflamed rats and rats with hindpaw inflammation. Eur Neurosci 18: 2239-2243, 2003.
19. Kwak JY, Jung JY, Hwang SW, Lee WT, and Oh U. A capsaicin-receptor antagonist, capsazepine, reduces inflammation-induced hyperalgesic responses in the rat: evidence for an endogenous capsaicin-like substance. Neuroscience 86: 619-626, 1998.
20. Martin WJ, Liu H, Wang H, Malmberg AB, and Basbaum AI. Inflammation-induced up-regulation of protein kinase C gamma immunoreactivity in rat spinal cord correlates with enhanced nociceptive processing. Neuroscience 88: 1267-1274, 1999.
21. Menetrey D and Besson JM. Electrophysiological characteristics of dorsal horn cells in rats with cutaneous inflammation resulting from chronic arthritis. Pain 13: 343-364, 1982.
22. Numazaki M, Tominaga T, Toyooka H, and Tominaga M. Direct phosphorylation of capsaicin receptor VR1 by protein kinase C epsilon and identification of two target serine residues. J Biol Chem 277: 13375-13378, 2002.
23. Olah Z, Karai L, and Iadarola MJ. Protein Kinase Ca is required for vanilloid receptor 1 activation. J Bio Chem 277: 35752-35759, 2002.
24. O'Sullivan S, Kendall DA, and Randall MD. Characterization of the vasorelaxant properties of the novel endocannabinoid N-arachidonoyl-dopamine (NADA). Br J Pharmacol 141: 803-812, 2004.
25. O'Sullivan SE, Kendall DA, and Randall MD. Vascular effects of delta 9-tetrahydrocannabinol (THC), anandamide and N-arachidonoyldopamine (NADA) in the rat isolated aorta. Eur J Pharmacol 507: 211-221, 2005.
26. Paxinos G and Watson C. The Rat Brain in Stereotaxic Coordinates (2nd ed.). Sydney: Academic, 1986.
27. Premkumar LS and Ahern GP. Induction of vanilloid receptor channel activity by protein kinase C. Nature 408: 985-990, 2000.
28. Premkumar LS, Qi Z-H, Van Buren J, and Raisinghani M. Enhancement of potency and efficacy by PKC-mediated phosphorylation of vanilloid receptor. J Neurophysiol 91: 1442-1449, 2004.
29. Price TJ, Patwardhan A, Akopian AN, Hargreaves KM, and Flores CM. Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide. Br J Pharmacol 141: 1118-1130, 2004.
30. Richardson JD, Kilo S, and Hargreaves KM. Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors. Pain 75: 111-119, 1998.
31. Rinaldi-Carmona M, Barth F, Heaulme M, Alonso R, Shire D, Congy C, Soubrie P, Breliere JC, and Le Fur G. Biochemical and pharmacological characterization of SR141716A, the first potent and selective brain cannabinoid receptor antagonist. Life Sci 56: 1941-1947, 1995.
32. Sagar DR, Smith PA, Millns PJ, Smart D, Kendall DA, and Chapman V. TRPV1 and CB1 receptor mediated effects of the endovanilloid/endocannabinoid N-arachidonoyl-dopamine on primary afferent fibre and spinal cord neuronal responses in the rat. Eur J Neuroci 20: 175-184, 2004.
33. Sancho R, Macho A, de La Vega L, Calzado MA, Fiebich BL, Appendino G, and Muñoz E. Immunosuppressive activity of endovanilloids: N-arachidonoyl-dopamine inhibits activation of the NF-kB, NFAT, and activator protein 1 signalling pathways. J Immunol 172: 2341-2351, 2004.
34. Santos ARS and Calixto JB. Ruthenium red and capsazepine antinociceptive effect in formalin and capsaicin models of pain in mice. Neurosci Lett 235: 73-76, 1997.
35. Sanudo-Pena MC, Strangman NM, Mackie K, Walker JM, and Tsou K. CB1 receptor localization in spinal cord and roots, dorsal root ganglion, and peripheral nerve. Acta Pharmacol Sin 12: 1115-1120, 1999.
36. Szallasi A. Autoradiographic visualization and pharmacological characterization of vanilloid (capsaicin) receptors in several species, including man. Acta Physiol Scand Suppl 629: 1-68, 1995.
37. Szallasi A, Nilsson S, Farkas-Szallasi T, Blumberg PM, Hokfelt T, and Lundberg JM. Vanilloid (capsaicin) receptors in the rat: distribution in the brain, regional differences in the spinal cord, axonal transport to the periphery, and depletion by systemic vanilloid treatment. Brain Res 703: 175-183, 1995.
38. Tominaga M, Caterina MJ, Malmberg AB, Rosen TA, Gilbert H, Skinner K, Raumann BE, Basbaum AI, and Julius D. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 21: 531-543, 1998.
39. Tominaga M, Wada M, and Masu M. Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia. Proc Natl Acad Sci USA 12: 6951-6956, 2001.
40. Torsney C and Fitzgerald M. Age-dependent effects of peripheral inflammation on the electrophysiological properties of neonatal rat dorsal horn neurons. J Neurophysiol 87: 1311-1317, 2002.
41. Tóth A, Kedei M, Wang Y, and Blumberg PM. Arachidonyl dopamine as a ligand for the vanilloid receptor VR1 of the rat. Life Sci 73: 487-498, 2003.
42. Vellani V, Mapplebeck S, Moriondo A, Davis JB, and McNaughton PA. Protein kinase C activation potentiates gating of the vanilloid receptor VR1 by capsaicin, protons, heat and anandamide. J Physiol 534: 813-825, 2001.